VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...
Randomized clinical trials remain the gold standard for causal inference, but many clinically important questions in oncology must be addressed using real-world observational data. This seminar will ...